Rotherham, Doncaster and South Humber NHS Foundation Trust patient group direction (PGD) for the supply of doxycycline for the treatment of uncomplicated chlamydia trachomatis, epididymo-orchitis uncomplicated mycoplasma genitalium and non-gonococcal and non-specific urethritis.
This patient group direction (PGD) must only be used by registered professionals who have been named and authorised by their organisation to practise under it.
This PGD template has been peer-reviewed by the reproductive health PGDs short life working group in accordance with their terms of reference. It has been approved by the British association for sexual health and HIV (BASHH) in April 2020.
To access this PGD please follow the link: Doxycycline chlamydia national PGD template v2.
To access the equality impact assessment for this policy, please see the overarching equality impact assessment.
Page last reviewed: April 30, 2024
Next review due: April 30, 2025